Radiotherapy Quality Management
Radialogica is a healthtech company focused on radiation oncology for cancer patients. We provide tools, evidence, and insight to manage the quality and safety of radiation treatment. Our goal is to enhance treatment quality, improve patient outcomes, and reduce the burden of cancer survivorship.
Our Mandate
Radialogica’s work is centered around quality in radiation oncology: how we define, measure, and manage treatment quality for the benefit of cancer patients and other stakeholders invested in their care.
Our Field
Radiation therapy is a proven and effective form of treatment for many types of cancer. According to the American Society for Radiation Oncology (ASTRO), nearly two-thirds of cancer patients in the United States, and over half of cancer patients worldwide, will receive radiation during their treatment.
Despite the high degree of computerization and automation that has come to define modern radiation oncology, there continues to exist significant variability in treatment planning and delivery. This variability can have direct consequences in terms of tumor control, toxicity, and patient response.
The inherent complexity of radiotherapy treatment requires rigorous quality assurance to ensure safe and effective care. The evaluation of treatment quality can be performed prior to the start of treatment, presenting an opportunity for real-time prospective review and potential intervention.
Our Business
Radialogica provides software and services, used in the clinic and in clinical trials, to evaluate and manage RT treatment quality and enhance outcomes for cancer patients.
RADIOTHERAPY QUALITY MANAGEMENT FOR ONCOLOGY TRIALS
Radialogica partners with study sponsors and CROs to manage the quality of radiation therapy in clinical trials. We work with big pharma, emerging biotech companies, and medical device manufacturers to design and implement RT QA programs that anticipate and address the unique clinical and operational requirements for trials that involve either on-study or prior RT. We leverage our deep clinical experience, proprietary software tools, and a technology infrastructure purpose-built for RT data acquisition and analysis to flexibly support the needs of small phase I studies through large, complex, global pivotal trials. Our study services span the development of RT treatment guidelines; collection and aggregation of RT data; extraction and evaluation of dosimetric parameters and other clinical quality measures; and comprehensive QA programs with prospective or retrospective case reviews and reporting.
We’ve collected and processed over 10,000 radiotherapy case submissions involving radiation treatment plan (DICOM-RT) files across a range of clinical and research projects including pharma and device trials, medical registries, payer benefits management, and provider quality benchmarking.
RADIOTHERAPY QUALITY MANAGEMENT FOR CLINICAL PRACTICE
Radialogica develops software tools to enhance the quality of radiotherapy treatment and improve the efficiency of clinical workflow. Our products are deployed within clinics and across networks to support a variety of use cases, including treatment plan QA, physician plan review, plan quality evaluation and benchmarking, independent peer review, and multi-disciplinary chart rounds.
Developed in collaboration with Prof. Dr. Markus Alber, SciMoCa™ combines the accuracy of Monte-Carlo dose calculations and the precision of custom beam models for robust dose verification and plan quality evaluation.
fullAccess™ is a fully integrated radiotherapy data display, communication and analysis platform that enables clinical across the continuum of care to access, analyze and share RT data.
Our tools have been installed at over 225 sites around the world and have impacted the quality of care for over 1.5 million patient treatments.
News & Information
Aarhus University Hospital Publishes Results of SciMoCa Software Comparison
Investigation quantifies the benefits of Monte Carlo dose computation and custom beam models for independent secondary dose calculation and patient-specific quality assurance. Research conducted by the Department of Oncology at Aarhus University Hospital in Denmark aimed to evidence the value of Monte Carlo dose calculation over analytical algorithms and the benefit of customized beam models […]
Clario expands oncology trial support through collaboration with Radialogica to enhance radiation therapy quality control
Solutions provide sponsors greater control and consistency when radiation therapy is part of the clinical trial protocol. Clario, a leading provider of endpoint data solutions to the clinical trials industry, has expanded its oncology trial support by collaborating with Radialogica to offer enhanced quality control for radiation therapy (RT). This new capability helps sponsors ensure […]
Radialogica to Support TRIBUTE Trial with Radiation Therapy Quality Assurance
Radialogica, a leading provider of radiation oncology quality management solutions, announced it has been selected by the Society of Interventional Oncology (SIO) to provide data collection, curation and analytics services for the TRIBUTE trial. TRIBUTE is a prospective, multi-center observational study evaluating patients with symptomatic, high-risk bone metastases treated with percutaneous ablation and palliative radiation […]